2023-11-14T21:33:46-06:00 2022-12-31 814234542 BPM LLP 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 940251021 990 2022-01-01 264443340 MEDICINES360 MEDI 4159518700 49 STEVENSON STREET 1100 SAN FRANCISCO CA 94105 BRADLEY LUKE CFO 4159518700 2023-11-14 1 BRADLEY LUKE 999009999 0 CAROLYN R AMSTER P00189994 6508556800 2023-11-14 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z ANDREA OLARIU 49 STEVENSON STREET 1100 SAN FRANCISCO CA 94105 43024866 0 X HTTP://WWW.MEDICINES360.ORG X 2009 CA MEDICINES360 IS A NON-PROFIT PHARMACEUTICAL ORGANIZATION THAT ADDRESSES UNMET NEEDS OF WOMEN BY DEVELOPING INNOVATIVE, AFFORDABLE AND SUSTAINABLE MEDICINES AND DEVICES 7 6 50 0 0 6956 31619 481076 0 0 13465173 132747 11178550 10320098 24675342 10933921 8000 3196 0 0 10531043 10173609 0 0 565375 12049897 8561974 22588940 18738779 2086402 -7804858 78136858 65028349 4024048 5787561 74112810 59240788 MEDICINES360 IS A NON-PROFIT PHARMACEUTICAL ORGANIZATION THAT ADDRESSES UNMET NEEDS OF WOMEN BY DEVELOPING INNOVATIVE, AFFORDABLE AND SUSTAINABLE MEDICINES AND DEVICES 0 0 13590446 3196 364380 THE ORGANIZATION RECEIVED NDA APPROVAL FOR ITS IUD PRODUCT LILETTA IN 2015. LILETTA HAS BEEN DISTRIBUTED THROUGH MEDICINES360'S COMMERCIAL PARTNER SINCE APRIL 2015. THE ORGANIZATION HAS CONTINUED CLINICAL TRIALS BEYOND THE INITIAL APPROVAL FOR THE PRODUCT. IN ADDITION, THE ORGANIZATION CONTINUES DEVELOPING CERTAIN MEDICAL PRODUCTS RELATING TO WOMEN'S REPRODUCTIVE HEALTH AND WORKS TO EXPAND ACCESS TO ALL WOMEN IN NEED. 13590446 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 1 55 0 1 50 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 7 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X NATALIE OTTEN 4159518700 49 STEVENSON STREET SUITE 1100 SAN FRANCISCO CA 94105 TINA RAINE-BENNET CEO 40.00 0.00 X X 620956 0 65392 LESLIE BENET CHAIR 2.00 0.00 X 60000 0 0 LISA DAVID DIRECTOR 2.00 0.00 X 40000 0 0 KAREN DAWES DIRECTOR 2.00 0.00 X 40000 0 0 ANN BARBER DIRECTOR 2.00 0.00 X 40000 0 0 MIKE DORSEY DIRECTOR 2.00 0.00 X 40000 0 0 ELIZABETH GARNER DIRECTOR 2.00 0.00 X 40000 0 0 BRADLEY LUKE CHIEF FINANCIAL OFFICER 36.30 3.70 X 442703 33707 21377 ETHAN K KNOWLDEN GENERAL COUNSEL/BOD SECRETARY 36.30 3.70 X 415245 31566 37524 SALLY STEPHENS CHIEF BUSINESS OFFICER (TO 5/13/22) 40.00 0.00 X 560808 0 15218 ANDREA I OLARIU CHIEF OPERATING OFFICER 22.35 17.65 X 345292 203525 96427 AUTUMN EHNOW EVP, POLICY AND STRATEGIC MARKET ACCESS 20.17 19.83 X 256407 171984 54952 MARK R BUSCH SVP, QUALITY ASSURANCE & PRODUCT SAFETY 26.47 13.53 X 317256 115490 31064 ROBERT DECKMAN VP, PRODUCT DEVELOPMENT & SUSTAIN ENG 40.00 0.00 X 349690 0 68775 MARGOT FAHNESTOCK VP, STRATEGIC DEVELOPMENT 40.00 0.00 X 316881 0 31147 STACEY MANLEY VP, COMMUNICATIONS & MARKETING 40.00 0.00 X 292956 0 40396 4178194 556272 462272 32 0 1 0 JPA HEALTH COMMUNICATIONS 1101 CONNECTICUT AVENUE NW STE 600 WASHINGTON DC 20036 CONSULTANT SERVICES 746246 PREMIER RESEARCH ACQUISITION CORPORATION ONE EAST 4TH STREET STE 1400 CINCINNATI OH 45202 CONSULTANT SERVICES 348447 WAXMAN STRATEGIES 4600 ROSWELL ROAD NE - BLDG H UNIT SANDY SPRINGS GA 30342 CONSULTANT SERVICES 297988 ACCUCLIN GLOBAL SERVICES LLC 746 UPPER GULPH RD WAYNE PA 19087 CONSULTANT SERVICES 281306 CAMBER COLLECTIVE LLC 2505 2ND AVENUE SUITE 415 SEATTLE WA 98121 CONSULTANT SERVICES 219450 15 481076 481076 1347289 1347289 9955718 9955718 30777555 31992097 -1214542 -1214542 -1214542 58691 98848 -40157 -40157 CO-PROMOTIONAL SALES 900099 401397 401397 OTHER REVENUE 900099 3140 3140 404537 10933921 364380 0 10088465 X 3196 3196 2840377 1387684 1417251 35442 5887562 4575505 1062941 249116 174025 119255 49056 5714 802789 567991 206418 28380 468856 321296 132165 15395 223150 188893 34257 111039 111039 37797 37797 179248 179248 4023731 3337445 561251 125035 1027740 1027740 550119 377024 155036 18059 574696 399262 156304 19130 524784 359622 147931 17231 185175 126896 52199 6080 898509 615727 253280 29502 UNRELATED BUSINESS INCO 1500 1500 PAYROLL PROCESS FEE 72990 50018 20575 2397 RECRUITING 66422 45517 18724 2181 EMPLOYEE EVENTS 30835 21131 8692 1012 54239 28447 15091 10701 18738779 13590446 4582958 565375 1433030 1633347 2061837 1863898 81083 9981 3208656 2991062 1154707 1039283 2444550 1817884 655747 626666 68171800 48005499 1000 1000 1368998 8857613 78136858 65028349 3755536 3408982 268512 2378579 4024048 5787561 X 74112810 59075817 164971 74112810 59240788 78136858 65028349 X -7804858 -7667684 600520 X 0 1 X 1 0 X UNIVERSITY OF CALIFORNIA DAVIS CA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 1 2288 0 1 43464 0 0 45752 0 PART II-B, LINE 1: MEDICINES360'S POLICY POSITIONS HAVE BEEN ROOTED IN EVIDENCE WITH A FOCUS ON PROVIDING A CORPORATE RESPONSE TO PROTECT AND CONVEY OUR MISSION AS A NON-PROFIT PHARMACEUTICAL ORGANIZATION FOCUSED ON WOMEN'S HEALTH. WE HAVE ACTIVELY ENGAGED WITH FEDERAL AND STATE POLICY MAKERS TO ADVOCATE FOR POLICY CHANGE THAT WOULD IMPROVE THE ABILITY OF A NONPROFIT PHARMACEUTICAL ORGANIZATION TO COMPLETE MISSION WORK. WE HAVE ALSO WORKED TO CONVEY OUR POSITION ON 340B POLICIES, TITLE X AND LARC RELATED AND DRAFT LEGISLATION. WE HAVE ALSO ISSUED MEDIA STATEMENTS ON OUR PRIORITY ISSUES AND PUBLIC COMMENT TO THE RECORD FOR SENATE AND HOUSE HEARINGS ON THESE TOPICS. 202736 44724 158012 1836848 1481455 355393 404966 291705 113261 626666 DEPOSIT 282945 INTERCOMPANY RECEIVABLE 491344 SERP RETIREMENT 289497 RIGHT OF USE ASSETS 2193307 CONVERTIBLE NOTE 5000000 CONVERTIBLE NOTE DISCOUNT 600520 8857613 DEFERRED LEASE LIABILITY 2378579 2378579 SOUTH ASIA 0 0 PROGRAM SERVICES 5575 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES 14566 EUROPE 0 0 PROGRAM SERVICES 125034 SUB-SAHARAN AFRICA 0 0 GRANTS 3196 CENTRAL AMERICA AND CARIBEAN 0 0 PROGRAM REVENUE - $33,250 SUB-SAHARAN AFRICA 0 0 PROGRAM REVENUE - $25,441 0 0 0 0 0 0 148371 0 148371 0 0 1 1 0 0 PART III ACCOUNTING METHOD: 1 X X X X X 1 0 0 0 0 0 0 1 0 TINA RAINE-BENNET CEO 516432 0 97000 0 7524 0 29650 0 35742 0 686348 0 97000 0 ANDREA I OLARIU CHIEF OPERATING OFFICER 256209 202331 87570 0 1513 1194 23993 5657 37317 29460 406602 238642 87570 0 SALLY STEPHENS CHIEF BUSINESS OFFICER (TO 5/13/22) 198244 0 122946 0 239618 0 9150 0 6068 0 576026 0 122946 0 BRADLEY LUKE CHIEF FINANCIAL OFFICER 324710 33246 113467 0 4526 461 8304 846 11096 1131 462103 35684 113466 0 ETHAN K KNOWLDEN GENERAL COUNSEL/BOD SECRETARY 300488 31105 110231 0 4526 461 8304 846 25749 2625 449298 35037 110231 0 AUTUMN EHNOW EVP, POLICY AND STRATEGIC MARKET ACC 168158 171094 87344 0 905 890 4613 4537 23093 22709 284113 199230 87344 0 MARK R BUSCH SVP, QUALITY ASSURANCE & PRODUCT SAF 218645 112367 92505 0 6106 3123 6054 3096 14499 7415 337809 126001 92505 0 ROBERT DECKMAN VP, PRODUCT DEVELOPMENT & SUSTAIN EN 268558 0 78425 0 2707 0 9150 0 59625 0 418465 0 78425 0 MARGOT FAHNESTOCK VP, STRATEGIC DEVELOPMENT 248048 0 66463 0 2370 0 9150 0 21997 0 348028 0 66463 0 STACEY MANLEY VP, COMMUNICATIONS & MARKETING 246764 0 44175 0 2017 0 9057 0 31339 0 333352 0 44175 0 PART I, LINE 7 EMPLOYEES OF MEDICINES360 RECEIVED DISCRETIONARY BONUSES THAT WERE APPROVED BY THE BOARD OF DIRECTORS AND DETERMINED BY THE FOLLOWING: 1. ELIGIBILITY 2. ACHIEVEMENT OF THE MEDICINES360 CONSOLIDATED CORPORATE GOALS 3. ACHIEVEMENT OF THE EMPLOYEE'S INDIVIDUAL GOALS 4. EMPLOYEE'S TARGET BONUS AS A PERCENTAGE OF SALARY AND ALLOCATION OF BONUS BETWEEN MEDICINES360 CONSOLIDATED CORPORATE GOALS AND INDIVIDUAL GOALS FOR THEIR LEVEL. 5. MANAGEMENT AND THE BOARD OF DIRECTORS' DISCRETION PART I, LINE 4A SALLY STEPHENS RECEIVED $235,942 OF SEVERANCE. FORM 990, PART VI, SECTION B, LINE 11B BEFORE FILING, THE TAX RETURN IS PROVIDED TO THE BOARD AUDIT COMMITTEE FOR THEIR REVIEW AND APPROVAL, AND THE FULL BOARD FOR THEIR REVIEW. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS/DIRECTORS ARE REQUIRED TO DISCLOSE OR UPDATE ANNUALLY INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE CEO COMPENSATION IS SET ON THE BASIS OF SALARY RANGES FOR COMPARABLY SIZED COMPANIES IN THE RADFORD GLOBAL LIFE SCIENCES SURVEY DATA AND COMPARABLE NON-PROFITS. THE COMPENSATION OF OFFICERS AND KEY EMPLOYEES ARE BENCH-MARKED AGAINST THE RADFORD GLOBAL LIFE SCIENCES SURVEY DATA AND COMPARABLE NON-PROFITS. THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE DATA AND COMPENSATION FOR THE CEO. THE COMPENSATION OF OFFICERS IS REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BOARD MEMBERS. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS: PROGRAM SERVICE EXPENSES 1,444,666. MANAGEMENT AND GENERAL EXPENSES 100,764. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,545,430. FDA FEES: PROGRAM SERVICE EXPENSES 375,543. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 375,543. OUTSOURCED SERVICES: PROGRAM SERVICE EXPENSES 1,517,236. MANAGEMENT AND GENERAL EXPENSES 460,487. FUNDRAISING EXPENSES 125,035. TOTAL EXPENSES 2,102,758. FORM 990, PART XI, LINE 9: AMORTIZATION OF DEBT ISSUANCE COSTS 46,520. UNREALIZED GAIN ON CONVERTIBLE DEBT 554,000. IMPACT RH360 LLC 49 STEVENSON ST SUITE 1100 SAN FRANCISCO CA 94105 MEDICAL PRODUCT DISTRIBUTION CA 58691 153059 MEDICINES360 CURAE PHARMA360 INC 49 STEVENSON ST SUITE 1100 SAN FRANCISCO CA 94105 460978720 MEDICAL PRODUCT SALES & DISTRIBUTION CA MEDICINES360 C 339765 2692181 1.00000 1 1 0 0 1 0 0 0 0 0 0 0 1 0 1 1 0 1 0 0 CURAE PHARMA360 INC A 277736 ACTUAL CURAE PHARMA360 INC D 5583003 ACTUAL CURAE PHARMA360 INC L 3140 ACTUAL CURAE PHARMA360 INC N 220427 ACTUAL CURAE PHARMA360 INC O 1266914 ACTUAL CURAE PHARMA360 INC Q 1487342 ACTUAL